ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,457Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 153

$463K Total Retail Price of All Prescriptions

Rank: 68 out of 153

425 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Florida
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 530 462 120 1 4
LEVOTHYROXINE SODIUM 457 428 86 2 2
FUROSEMIDE 393 364 72 3 6
LISINOPRIL 350 336 71 4 5
SIMVASTATIN 341 310 85 5 1
AMLODIPINE BESYLATE 333 313 73 6 3
LOSARTAN POTASSIUM 230 208 50 7 10
METOPROLOL TARTRATE 212 198 48 8 7
HYDROCODONE-ACETAMINOPHEN 205 186 37 S3 9 15
POTASSIUM CHLORIDE 188 183* 35 10 20
METFORMIN HCL 151 124 40 11 9
WARFARIN SODIUM 149 144* 23 12 11
GABAPENTIN 138 96 31 13 13
ATENOLOL 135 113 30 14 16
METOPROLOL SUCCINATE 132 127* 33 15 21
CYMBALTA 132 120 16 15 47
TRAMADOL HCL 132 103 46 15 22
CITALOPRAM HBR 128 108 25 18 23
HYDROCHLOROTHIAZIDE 128 123* 32 18 19
TEMAZEPAM 120 115* 23 B 20 28
LORAZEPAM 119 119 21 B 21 30
FENOFIBRATE* 117 99 30 22 63
ALPRAZOLAM 114 109* 30 B 23 12
LOVASTATIN 106 101* 25 24 44
FLUTICASONE PROPIONATE 94 89* 40 25 37
CARVEDILOL 92 87* 18 26 24
ATORVASTATIN CALCIUM 90 85* 21 27 8
PREDNISONE 89 84* 23 28 45
NAMENDA 88 <11 <11 29 17
ZOLPIDEM TARTRATE 86 81* 13 30 27
TAMSULOSIN HCL 84 84 16 31 31
CLONIDINE HCL 77 72* 14 32 64
ENALAPRIL MALEATE 74 62 19 33 46
ISOSORBIDE MONONITRATE ER 72 67* 17 34 62
CLOPIDOGREL 71 66* 14 35 14
SERTRALINE HCL 69 46 14 36 26
DONEPEZIL HCL 67 62* 15 37 18
LANTUS 67 <11 <11 37 61
MONTELUKAST SODIUM 67 62* 17 37 51
VENTOLIN HFA 66 61* 29 40 117
SPIRONOLACTONE 62 57* 13 41 75
NITROFURANTOIN MONO-MACRO 62 57* 14 41 186
SPIRIVA 62 57* 15 41 87
LEVOFLOXACIN 61 56* 42 44 70
XARELTO 59 <11 <11 45 119
CIPROFLOXACIN HCL 54 49* 31 46 57
ESCITALOPRAM OXALATE 54 <11 <11 46 33
ALBUTEROL SULFATE 54 <11 <11 46 124
FOLIC ACID 51 46* 11 49 123
FAMOTIDINE* 50 39 19 50 58
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.